Harnessing ZIKV NS2A RNA for alleviating acute hepatitis and cytokine release storm by targeting translation machinery
Open Access
- 20 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 82 (1) , 110-126
Abstract
Background and Aims: Hyperactivated inflammatory responses induced by cytokine release syndrome are the primary causes of tissue damage and even death. The translation process is precisely regulated to control the production of proinflammatory cytokines. However, it is largely unknown whether targeting translation can effectively limit the hyperactivated inflammatory responses during acute hepatitis and graft-versus-host disease. Approach and Results: By using in vitro translation and cellular overexpression systems, we have found that the nonstructural protein gene NS2A of Zika virus functions as RNA molecules to suppress the translation of both ectopic genes and endogenous proinflammatory cytokines. Mechanistically, results from RNA pulldown and co-immunoprecipitation assays have demonstrated that NS2A RNA interacts with the translation initiation factor eIF2α to disrupt the dynamic balance of the eIF2/eIF2B complex and translation initiation, which is the rate-limiting step of translation. In the acetaminophen-induced, lipopolysaccharide/D-galactosamine-induced, viral infection-induced acute hepatitis, and graft-versus-host disease mouse models, mice with myeloid cell-specific knock-in of NS2A show decreased levels of serum proinflammatory cytokines and reduced tissue damage. Conclusions: Zika virus NS2A dampens the production of proinflammatory cytokines and alleviates inflammatory injuries by interfering translation process as RNA molecules, which suggests that NS2A RNA is potentially used to treat numerous acute inflammatory diseases characterized by cytokine release syndrome.Keywords
This publication has 47 references indexed in Scilit:
- Lipid Nanoparticles Optimized for Targeting and Release of Nucleic AcidAdvanced Materials, 2023
- Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapiesLife Sciences, 2021
- The ‘cytokine storm’: molecular mechanisms and therapeutic prospectsTrends in Immunology, 2021
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNAMolecular Cell, 2020
- SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host DefensesCell, 2020
- Targeting Interleukin-6 Signaling in ClinicImmunity, 2019
- Viral internal ribosomal entry sites: four classes for one goalWIREs RNA, 2017
- Structural Changes Enable Start Codon Recognition by the Eukaryotic Translation Initiation ComplexCell, 2014
- Anti-apoptotic activity of gentiopicroside in d-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failureChemico-Biological Interactions, 2010
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological TargetsCell, 2009